Ginkgo unveils its stock ticker, a biotech venture fund raises $515m, and a unicorn is born
By Anissa Gardizy Globe Staff,Updated May 14, 2021, 2 hours ago
Email to a Friend
Jason Kelly, cofounder and chief executive of Ginkgo Bioworks.Scott Eisen/Bloomberg
Hereâs a roundup of five local life-science deals and fundraising events that people are talking about this week.
Ginkgo Bioworks
After announcing a $17.5 billion merger with a SPAC (blank check company) earlier this week, Ginkgo Bioworks on Friday (finally) unveiled its stock ticker as it plans to go public: âDNA.â The biotech explained in a Twitter thread why it chose the ticker, which was first used by Genentech before it was acquired, and why it decided against more obvious trading symbols, such as âGKGOâ or âCELL.â